What Will it Mean for Humanity if Artificial Intelligence Solves ALS?
Source: Pixabay

What Will it Mean for Humanity if Artificial Intelligence Solves ALS?

In 2014, Stephen Hawking, one of the world's leading thinkers and most famous faces of amyotrophic lateral sclerosis (ALS), spoke out about the dangers of full artificial intelligence (AI). Hawking…

Continue Reading What Will it Mean for Humanity if Artificial Intelligence Solves ALS?
A Path Leads to an IPF Breakthrough: British Scientists Discover Lung Fibrosis Gene
Pexels / Pixabay

A Path Leads to an IPF Breakthrough: British Scientists Discover Lung Fibrosis Gene

Health scientists at the University of Leicester and University of Nottingham have heralded the discovery of a gene associated with lung fibrosis, such as idiopathic pulmonary fibrosis (IPF), as "a…

Continue Reading A Path Leads to an IPF Breakthrough: British Scientists Discover Lung Fibrosis Gene
Is Zika a Risk Factor For Guillain-Barre Syndrome? New Research Sheds Light
Source: pixabay.com

Is Zika a Risk Factor For Guillain-Barre Syndrome? New Research Sheds Light

You may have heard the buzz during the Zika outbreak in 2016. Many professionals suspected a relationship between the Zika virus and Guillain Barre Syndrome (GBS). Guillain Barre Syndrome is…

Continue Reading Is Zika a Risk Factor For Guillain-Barre Syndrome? New Research Sheds Light
Research Team Develops New, Easier Method for Diagnosing and Measuring Gaucher Disease
Source: Pixabay

Research Team Develops New, Easier Method for Diagnosing and Measuring Gaucher Disease

A team of researchers at the Cincinnati Children’s Hospital Medical Center has developed a method to test for Gaucher disease using dried blood samples - marking a big breakthrough for the Gaucher…

Continue Reading Research Team Develops New, Easier Method for Diagnosing and Measuring Gaucher Disease
How Thinking Like a Tech Start Up Led to Strides Forward in NGLY1 Deficiency Research
Source: Pixabay

How Thinking Like a Tech Start Up Led to Strides Forward in NGLY1 Deficiency Research

Rare disease research can feel like an uphill battle. First of all, rare diseases have a harder time receiving funding. After that, it takes months or even years to have…

Continue Reading How Thinking Like a Tech Start Up Led to Strides Forward in NGLY1 Deficiency Research